Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Asian Pacific journal of cancer prevention : APJCP 2019-03

Relation between Tetraspanin- Associated and Tetraspanin- Non- Associated Exosomal Proteases and Metabolic Syndrome in Colorectal Cancer Patients

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Линкът е запазен в клипборда
Elena Tugutova
Svetlana Tamkovich
Marina Patysheva
Sergey Afanas’ev
Anastasia Tsydenova
Alina Grigor’eva
Elena Kolegova
Irina Kondakova
Natalia Yunusova

Ключови думи

Резюме

Purpose: Exosomal proteases are important in regulation of molecular signaling from growth factor receptors andadhesion molecules and also the regulation of cell motility and protein folding. The aim of this study was to evaluatethe level of ADAM10, ADAM17 and 20S proteasomes in exosomes isolated from colorectal cancer patients (CRCPs)in relation with clinical and histopathological parameters. Methods: Blood plasma exosomes of 60 CRCPs at stageT2-4N0-2M0-1 and 10 control subjects (CSs) with colorectal polyps were isolated using ultrafiltration in combinationwith ultracentrifugation. The level of tetraspanin-associated (ADAM20 and ADAM17) and tetraspanin-non-associated(20S proteasome) proteases were evaluated by flow cytometry and western blot analysis. Results: The ADAM10-/ADAM17- population predominated in plasma exosomes of CRCPs and the level of ADAM10+ exosomes wassignificantly higher in exosomes of CSs compared with CRCPs. No difference was found between subpopulationsof ADAM10/ADAM17 exosomes and level of exosomal 20S proteasomes in terms of sex, age and tumor grade.Simultaneous decrease of ADAM10+/ADAM17-subpopulation of exosomes and level of exosomal 20S proteasomes inpatients with metastatic CRC was observed compared with patients with non-metastatic CRC. The level of ADAM17+exosomes significantly reduced in exosomes of CRCPs with metabolic syndrome compared to CRCPs withoutmetabolic syndrome( 3.97±0.71 (%) vs. 13.04±1.34 (%), respectively (p<0.05). A decrease in the 20S proteasomeslevel in plasma exosomes was revealed in CRCPs with metabolic syndrome compared with CRCPs without metabolicdisorders ( 1.90±0.25 (r.u.) vs. 2.92±0.42 (r.u.) respectively( (p<0.05). Conclusion: According to findings of this study,it seems that exosomal proteases can be promising molecular predictors of hematogenous metastasis in patients withnon-metastatic CRC. Further studies on subpopulation composition of exosomes CRCPs are need for elucidating therole of tetraspanin-associated and tetraspanin-non-associated exosomal proteases in CRC development and progression.

Присъединете се към нашата
страница във facebook

Най-пълната база данни за лечебни билки, подкрепена от науката

  • Работи на 55 езика
  • Билкови лекове, подкрепени от науката
  • Разпознаване на билки по изображение
  • Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
  • Прочетете научни публикации, свързани с вашето търсене
  • Търсете лечебни билки по техните ефекти
  • Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания

Google Play badgeApp Store badge